title: STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease.
abstract: STAT4, a critical regulator of inflammation in vivo, can be expressed as two alternative splice forms, a full-length STAT4alpha, and a STAT4beta isoform lacking a C-terminal transactivation domain. Each isoform is sufficient to program Th1 development through both common and distinct subsets of target genes. However, the ability of these isoforms to mediate inflammation in vivo has not been examined. Using a model of colitis that develops following transfer of CD4(+) CD45RB(high) T cells expressing either the STAT4alpha or STAT4beta isoform into SCID mice, we determined that although both isoforms mediate inflammation and weight loss, STAT4beta promotes greater colonic inflammation and tissue destruction. This correlates with STAT4 isoform-dependent expression of TNF-alpha and GM-CSF in vitro and in vivo, but not Th1 expression of IFN-gamma or Th17 expression of IL-17, which were similar in STAT4alpha- and STAT4beta-expressing T cells. Thus, higher expression of a subset of inflammatory cytokines from STAT4beta-expressing T cells correlates with the ability of STAT4beta-expressing T cells to mediate more severe inflammatory disease.
authors.affiliation: Department of Pediatrics, HB Wells Center for Pediatric Research and Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: John T
authors.initials: JT
authors.lastname: O'Malley
authors.forename: Rajaraman D
authors.initials: RD
authors.lastname: Eri
authors.forename: Gretta L
authors.initials: GL
authors.lastname: Stritesky
authors.forename: Anubhav N
authors.initials: AN
authors.lastname: Mathur
authors.forename: Hua-Chen
authors.initials: HC
authors.lastname: Chang
authors.forename: Harm
authors.initials: H
authors.lastname: Hogenesch
authors.forename: Mythily
authors.initials: M
authors.lastname: Srinivasan
authors.forename: Mark H
authors.initials: MH
authors.lastname: Kaplan
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis*; D005260:Female; D018836:Inflammation Mediators / Q000378:metabolism / Q000502:physiology*; D015212:Inflammatory Bowel Diseases / Q000235:genetics / Q000276:immunology* / Q000473:pathology*; D017710:Lymphocyte Transfusion; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D016513:Mice, SCID; D008822:Mice, Transgenic; D020033:Protein Isoforms / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D017434:Protein Structure, Tertiary / Q000235:genetics; D011948:Receptors, Antigen, T-Cell / Q000502:physiology; D050797:STAT4 Transcription Factor / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D017384:Sequence Deletion; D012720:Severity of Illness Index; D018417:Th1 Cells / Q000276:immunology* / Q000378:metabolism / Q000637:transplantation; D015533:Transcriptional Activation / Q000235:genetics / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D015854:Up-Regulation / Q000235:genetics / Q000276:immunology; D015431:Weight Loss / Q000235:genetics / Q000276:immunology
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D020033:Protein Isoforms; D011948:Receptors, Antigen, T-Cell; D050797:STAT4 Transcription Factor; C494091:Stat4 protein, mouse; D014409:Tumor Necrosis Factor-alpha
references.citation: J Exp Med. 1999 Nov 15;190(10):1479-92
references.pmid: 10562322
references.citation: Blood. 1996 Oct 1;88(7):2442-9
references.pmid: 8839834
references.citation: Genes Dev. 2000 Jul 15;14(14):1693-711
references.pmid: 10898785
references.citation: J Interferon Cytokine Res. 2000 Oct;20(10):897-905
references.pmid: 11054278
references.citation: Immunity. 2000 Nov;13(5):715-25
references.pmid: 11114383
references.citation: J Immunol. 2000 Dec 15;165(12):6803-8
references.pmid: 11120802
references.citation: J Immunol. 2000 Dec 15;165(12):7234-9
references.pmid: 11120856
references.citation: J Immunol. 1999 Mar 15;162(6):3702-10
references.pmid: 10092833
references.citation: Mamm Genome. 2004 Nov;15(11):865-71
references.pmid: 15672590
references.citation: Gastroenterology. 2005 Mar;128(3):687-94
references.pmid: 15765404
references.citation: Immunogenetics. 2005 Mar;56(12):861-70
references.pmid: 15778901
references.citation: Immunol Res. 2005;31(3):231-42
references.pmid: 15888914
references.citation: Blood. 2005 Aug 1;106(3):963-70
references.pmid: 15817683
references.citation: J Immunol. 2005 Nov 1;175(9):5981-5
references.pmid: 16237092
references.citation: Am J Pathol. 1997 Mar;150(3):823-32
references.pmid: 9060820
references.citation: Crit Rev Immunol. 1997;17(3-4):301-23
references.pmid: 9202885
references.citation: Immunology. 1997 Jun;91(2):281-8
references.pmid: 9227329
references.citation: J Immunol. 1997 Dec 15;159(12):6276-82
references.pmid: 9550432
references.citation: J Exp Med. 1998 Apr 20;187(8):1225-34
references.pmid: 9547334
references.citation: Leuk Lymphoma. 1998 Aug;30(5-6):433-42
references.pmid: 9711905
references.citation: J Immunol. 1999 Feb 15;162(4):1884-8
references.pmid: 9973454
references.citation: J Exp Med. 2006 Oct 30;203(11):2473-83
references.pmid: 17030949
references.citation: J Immunol. 2007 Mar 15;178(6):3427-36
references.pmid: 17339437
references.citation: J Immunol. 2007 Apr 15;178(8):4901-7
references.pmid: 17404271
references.citation: Respir Med. 2007 Sep;101(9):1977-81
references.pmid: 17532201
references.citation: Gastroenterol Nurs. 2007 Jul-Aug;30(4):278-82; quiz 283-4
references.pmid: 17724402
references.citation: N Engl J Med. 2007 Sep 6;357(10):977-86
references.pmid: 17804842
references.citation: Mol Med. 2007 Sep-Oct;13(9-10):455-60
references.pmid: 17932559
references.citation: Cell Immunol. 2007 Aug;248(2):115-20
references.pmid: 18048021
references.citation: J Immunol. 2008 Mar 1;180(5):3551-9
references.pmid: 18292582
references.citation: Inflamm Bowel Dis. 2008 Apr;14(4):458-70
references.pmid: 18186109
references.citation: Immunity. 2001 Mar;14(3):205-15
references.pmid: 11290331
references.citation: Lancet. 2002 May 4;359(9317):1541-9
references.pmid: 12047962
references.citation: J Immunol. 2002 Oct 15;169(8):4388-98
references.pmid: 12370372
references.citation: J Exp Med. 2006 Oct 30;203(11):2485-94
references.pmid: 17030948
references.citation: J Biol Chem. 2003 Jan 17;278(3):1910-4
references.pmid: 12417590
references.citation: EMBO J. 2003 Aug 15;22(16):4237-48
references.pmid: 12912921
references.citation: Int Immunol. 2004 Feb;16(2):295-302
references.pmid: 14734615
references.citation: Eur J Gastroenterol Hepatol. 2004 Jul;16(7):649-55
references.pmid: 15201577
references.citation: Annu Rev Immunol. 1989;7:145-73
references.pmid: 2523712
references.citation: Cell Immunol. 1995 Mar;161(1):125-31
references.pmid: 7867077
references.citation: Science. 1995 Nov 17;270(5239):1215-8
references.pmid: 7502050
references.citation: Eur J Immunol. 1996 Jul;26(7):1647-51
references.pmid: 8766574
references.citation: Nature. 1996 Jul 11;382(6587):174-7
references.pmid: 8700209
references.citation: J Immunol. 1996 Aug 1;157(3):1261-70
references.pmid: 8757634
references.citation: Nat Med. 2000 May;6(5):583-8
references.pmid: 10802717